The value of CHA2DS2-VASc-HS score for prediction of adverse in-hospital outcomes in patients with non-ST segment elevation myocardial infarction | ||||
Benha Journal of Applied Sciences | ||||
Article 29, Volume 6, Issue 4, August 2021, Page 191-196 PDF (498.83 K) | ||||
Document Type: Original Research Papers | ||||
DOI: 10.21608/bjas.2021.189923 | ||||
![]() | ||||
Authors | ||||
M.K. Mahmoud; H.M. Kabil; H.H. Ebed; A.M. Sabry | ||||
Cardiology, Dept., Faculty of Medicine, Benha Univ., Benha, Egypt | ||||
Abstract | ||||
For a treatment choice the early identification of non-ST myocardial infarction segment patients (NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc score was recently reported as a predictor of severity and poor outcomes in individuals with stable coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been computed. The participants of the research were split into two groups. Group I and Group II score <4 were placed in Patients with CHA2DS2-VASc-HS score>4. Patients with CHA2DS2-VASc-HS >4 were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score <4. | ||||
Keywords | ||||
Ischemic heart disease; CHA2DS2-VASc-HS score; adverse in-hospital outcomes; non-ST segment elevation myocardial infarction | ||||
Statistics Article View: 112 PDF Download: 322 |
||||